(Q45239039)
Statements
1 reference
An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: efavirenz and nevirapine (English)
1 reference
Roberto Manfredi
1 reference
Leonardo Calza
1 reference
Francesco Chiodo
1 reference
1 February 2005
1 reference
1 reference
38
1 reference
2
1 reference
236-238
1 reference
Identifiers
1 reference
1 reference